Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31


Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.

Malerba A, Roth F, Harish P, Dhiab J, Lu-Nguyen N, Cappellari O, Jarmin S, Mahoudeau A, Ythier V, Lainé J, Negroni E, Abgueguen E, Simonelig M, Guedat P, Mouly V, Butler-Browne G, Voisset C, Dickson G, Trollet C.

Hum Mol Genet. 2019 Jan 14. doi: 10.1093/hmg/ddz007. [Epub ahead of print]


The role of Pitx2 and Pitx3 in muscle stem cells gives new insights into P38α MAP kinase and redox regulation of muscle regeneration.

L'honoré A, Commère PH, Negroni E, Pallafacchina G, Friguet B, Drouin J, Buckingham M, Montarras D.

Elife. 2018 Aug 14;7. pii: e32991. doi: 10.7554/eLife.32991.


Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

Ladislau L, Portilho DM, Courau T, Solares-Pérez A, Negroni E, Lainé J, Klatzmann D, Bonomo A, Allenbach Y, Benveniste O, Riederer I, Savino W, Mouly V, Butler-Browne G, Benjamim CF.

Cell Death Dis. 2018 May 1;9(5):551. doi: 10.1038/s41419-018-0426-z.


Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.

Cordova G, Negroni E, Cabello-Verrugio C, Mouly V, Trollet C.

Front Genet. 2018 Apr 10;9:114. doi: 10.3389/fgene.2018.00114. eCollection 2018. Review.


Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Lorant J, Saury C, Schleder C, Robriquet F, Lieubeau B, Négroni E, Leroux I, Chabrand L, Viau S, Babarit C, Ledevin M, Dubreil L, Hamel A, Magot A, Thorin C, Guevel L, Delorme B, Péréon Y, Butler-Browne G, Mouly V, Rouger K.

Mol Ther. 2018 Feb 7;26(2):618-633. doi: 10.1016/j.ymthe.2017.10.013. Epub 2017 Oct 20.


Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model.

Santos-Zas I, Negroni E, Mamchaoui K, Mosteiro CS, Gallego R, Butler-Browne GS, Pazos Y, Mouly V, Camiña JP.

Mol Ther. 2017 Oct 4;25(10):2345-2359. doi: 10.1016/j.ymthe.2017.06.022. Epub 2017 Jul 24.


CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Pinto-Mariz F, Rodrigues Carvalho L, Prufer De Queiroz Campos Araujo A, De Mello W, Gonçalves Ribeiro M, Cunha Mdo C, Cabello PH, Riederer I, Negroni E, Desguerre I, Veras M, Yada E, Allenbach Y, Benveniste O, Voit T, Mouly V, Silva-Barbosa SD, Butler-Browne G, Savino W.

Skelet Muscle. 2015 Dec 10;5:45. doi: 10.1186/s13395-015-0066-2. eCollection 2015.


Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.

Negroni E, Bigot A, Butler-Browne GS, Trollet C, Mouly V.

Hum Gene Ther. 2016 Feb;27(2):117-26. doi: 10.1089/hum.2015.139. Epub 2016 Jan 25. Review.


Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle.

Bigot A, Duddy WJ, Ouandaogo ZG, Negroni E, Mariot V, Ghimbovschi S, Harmon B, Wielgosik A, Loiseau C, Devaney J, Dumonceaux J, Butler-Browne G, Mouly V, Duguez S.

Cell Rep. 2015 Nov 10;13(6):1172-1182. doi: 10.1016/j.celrep.2015.09.067. Epub 2015 Oct 29.


Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.

Negroni E, Gidaro T, Bigot A, Butler-Browne GS, Mouly V, Trollet C.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):270-87. doi: 10.1111/nan.12198. Review.


Altered cross-bridge properties in skeletal muscle dystrophies.

Guellich A, Negroni E, Decostre V, Demoule A, Coirault C.

Front Physiol. 2014 Oct 14;5:393. doi: 10.3389/fphys.2014.00393. eCollection 2014. Review.


Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.

Negroni E, Henault E, Chevalier F, Gilbert-Sirieix M, Van Kuppevelt TH, Papy-Garcia D, Uzan G, Albanese P.

J Neuropathol Exp Neurol. 2014 Aug;73(8):789-97. doi: 10.1097/NEN.0000000000000098.


Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies.

Chevalier F, Lavergne M, Negroni E, Ferratge S, Carpentier G, Gilbert-Sirieix M, Siñeriz F, Uzan G, Albanese P.

Stem Cell Res. 2014 May;12(3):703-15. doi: 10.1016/j.scr.2014.03.001. Epub 2014 Mar 10.


The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.

Vallese D, Negroni E, Duguez S, Ferry A, Trollet C, Aamiri A, Vosshenrich CA, Füchtbauer EM, Di Santo JP, Vitiello L, Butler-Browne G, Mouly V.

Mol Ther. 2013 Oct;21(10):1950-7. doi: 10.1038/mt.2013.186. Epub 2013 Aug 23.


Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.

Gidaro T, Negroni E, Perié S, Mirabella M, Lainé J, Lacau St Guily J, Butler-Browne G, Mouly V, Trollet C.

J Neuropathol Exp Neurol. 2013 Mar;72(3):234-43. doi: 10.1097/NEN.0b013e3182854c07.


Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation.

Bencze M, Negroni E, Vallese D, Yacoub-Youssef H, Chaouch S, Wolff A, Aamiri A, Di Santo JP, Chazaud B, Butler-Browne G, Savino W, Mouly V, Riederer I.

Mol Ther. 2012 Nov;20(11):2168-79. doi: 10.1038/mt.2012.189. Epub 2012 Oct 16.


Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.

Krom YD, Dumonceaux J, Mamchaoui K, den Hamer B, Mariot V, Negroni E, Geng LN, Martin N, Tawil R, Tapscott SJ, van Engelen BG, Mouly V, Butler-Browne GS, van der Maarel SM.

Am J Pathol. 2012 Oct;181(4):1387-401. doi: 10.1016/j.ajpath.2012.07.007. Epub 2012 Aug 4.


Myf5 haploinsufficiency reveals distinct cell fate potentials for adult skeletal muscle stem cells.

Gayraud-Morel B, Chrétien F, Jory A, Sambasivan R, Negroni E, Flamant P, Soubigou G, Coppée JY, Di Santo J, Cumano A, Mouly V, Tajbakhsh S.

J Cell Sci. 2012 Apr 1;125(Pt 7):1738-49. doi: 10.1242/jcs.097006. Epub 2012 Feb 24. Erratum in: J Cell Sci. 2012 Dec 15;125(Pt 24):6198.


Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders.

Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, Kandalla PK, Marie S, Di Santo J, St Guily JL, Muntoni F, Kim J, Philippi S, Spuler S, Levy N, Blumen SC, Voit T, Wright WE, Aamiri A, Butler-Browne G, Mouly V.

Skelet Muscle. 2011 Nov 1;1:34. doi: 10.1186/2044-5040-1-34.


Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration.

Riederer I, Negroni E, Bencze M, Wolff A, Aamiri A, Di Santo JP, Silva-Barbosa SD, Butler-Browne G, Savino W, Mouly V.

Mol Ther. 2012 Jan;20(1):146-54. doi: 10.1038/mt.2011.193. Epub 2011 Sep 20.


Current advances in cell therapy strategies for muscular dystrophies.

Negroni E, Vallese D, Vilquin JT, Butler-Browne G, Mouly V, Trollet C.

Expert Opin Biol Ther. 2011 Feb;11(2):157-76. doi: 10.1517/14712598.2011.542748. Review.


Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.

Trollet C, Anvar SY, Venema A, Hargreaves IP, Foster K, Vignaud A, Ferry A, Negroni E, Hourde C, Baraibar MA, 't Hoen PA, Davies JE, Rubinsztein DC, Heales SJ, Mouly V, van der Maarel SM, Butler-Browne G, Raz V, Dickson G.

Hum Mol Genet. 2010 Jun 1;19(11):2191-207. doi: 10.1093/hmg/ddq098. Epub 2010 Mar 5.


In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study.

Negroni E, Riederer I, Chaouch S, Belicchi M, Razini P, Di Santo J, Torrente Y, Butler-Browne GS, Mouly V.

Mol Ther. 2009 Oct;17(10):1771-8. doi: 10.1038/mt.2009.167. Epub 2009 Jul 21.


Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.

Chaouch S, Mouly V, Goyenvalle A, Vulin A, Mamchaoui K, Negroni E, Di Santo J, Butler-Browne G, Torrente Y, Garcia L, Furling D.

Hum Gene Ther. 2009 Jul;20(7):784-90. doi: 10.1089/hum.2008.163.


Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice.

Riederer I, Negroni E, Bigot A, Bencze M, Di Santo J, Aamiri A, Butler-Browne G, Mouly V.

Transplant Proc. 2008 Mar;40(2):624-30. doi: 10.1016/j.transproceed.2008.01.026.


Myoblast transfer therapy: is there any light at the end of the tunnel?

Mouly V, Aamiri A, Périé S, Mamchaoui K, Barani A, Bigot A, Bouazza B, François V, Furling D, Jacquemin V, Negroni E, Riederer I, Vignaud A, St Guily JL, Butler-Browne GS.

Acta Myol. 2005 Oct;24(2):128-33. Review.


Myogenic stem cells: regeneration and cell therapy in human skeletal muscle.

Negroni E, Butler-Browne GS, Mouly V.

Pathol Biol (Paris). 2006 Mar;54(2):100-8. Epub 2005 Oct 21. Review.


The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy.

Mouly V, Aamiri A, Bigot A, Cooper RN, Di Donna S, Furling D, Gidaro T, Jacquemin V, Mamchaoui K, Negroni E, Périé S, Renault V, Silva-Barbosa SD, Butler-Browne GS.

Acta Physiol Scand. 2005 May;184(1):3-15. Review.


Activity of 3-ketosphinganine synthase during differentiation and aging of neuronal cells in culture.

Chigorno V, Negroni E, Nicolini M, Sonnino S.

J Lipid Res. 1997 Jun;38(6):1163-9.


Evaluation of the efficiency of an assay procedure for gangliosides in human serum.

Negroni E, Chigorno V, Tettamanti G, Sonnino S.

Glycoconj J. 1996 Jun;13(3):347-52.


[Role of the hospital environment in diffusion of viral hepatitis (descriptive survey)].

Castagnari L, Gasparini V, Menini C, Maggi A, Negroni E.

Nuovi Ann Ig Microbiol. 1977 Jan-Feb;28(1):3-14. Italian. No abstract available.


Supplemental Content

Loading ...
Support Center